K. Nemoto, et al., Prostaglandins 54:713-725, 1997, pp. 713-725, “Molecular Cloning and Expression of a Rat Prostaglandin E2 Receptor of the EP2 Subtype”. |
M. Suda, et al., Endocrinology vol. 137, No. 5, pp. 1698-1705, “Prostaglandin E Receptor Subtypes in Mouse Osteoblastic Cell Line (1996)”. |
S. Kasugai, et al., Bone, vol. 17, No. 1, Jul. 1995, pp. 1-4, “Expression of Prostaglandin E Receptor Subtypes in Bone: Expression of EP2 in Bone Development”. |
A. Scutt, et al., Prostaglandins 49:383-395, 1995 “PGE2 Induces the Transition from Non-Adherent to Adherent Bone Marrow Mesenchymal Precursor Cells Via a cAMP/EP2-Mediated Mechanism”. |
F. N. Woodiel, et al., Journal of Bone and Mineral Research, vol. 11, No. 9, 1996 pp. 1249-1255, “Anabolic Effects of Prostaglandins in Cultured Fetal Rate Calvariare: Structure-Activity Relations and Signal Transduction Pathway”. |
C. D. Funk, et al., The Journal of Biological Chemistry, 1993 vol. 268, No. 35 pp. 26767-26772, “Cloning and Expression of a cDNA for the Human Prostaglandin E Receptor EP1 Subtype”. |
J. W. Regan, et al., The American Society for Pharmacology and Experimental Therapeutics,—Molecular Pharmacology, 46:213-220, 1994 “Cloning of a Novel Human Prostaglandin Receptor with Characteristics of the Pharmacologically Defined EP2 Subtype”. |
J. Yang., et al., Biochemical and Biophysical Research Communications, vol. 198, No. 3, 1994, pp. 999-1006, “Cloning and Expression of the EP3-Subtype of Human Receptors for Prostaglandin E2”. |
L. Bastien, The Journal of Biological Chemistry, vol. 269, No. 16, Apr. 22, pp. 11873-11877, 1994, “Cloning, Functional Expression, and Characterization of the Human Prostaglandin E2 Receptor EP2 Subtype”. |
T. Ohta, et al., The Journal of Pharm & Experimental Thereapeutics, vol. 275, No. 1, 1995, pp. 450-455, “TEI-3313, a Novel Prostaglandin A1 Derivative, Prevents Bone Loss and Enhances Bone Formation in Immobilized Male Rats”. |
J. Bone Miner. Res. 1996, 11(supp.):S174, (S337,S338). |